COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff
- Conditions
- COVID
- Interventions
- Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2
- Registration Number
- NCT04346186
- Lead Sponsor
- Herlev Hospital
- Brief Summary
During the COVID-19 pandemic several countries have seen a high risk of transmission for health care personnel, with some countries having as many 20-25% of nurses and doctors either infected or showing symptoms of COVID-19.
In this prospective cohort study, we will systematically screen all hospital staff in the Capital Region of Denmark for IgM and IgG antibodies against SARS-CoV-2 using a point of care tests and an Elisa kit.
Testing will be offered 3 times: In April 2020, Maj 2020 and September 2020. All participants will submit a questionnaire regarding exposures, risk factors and symptoms of COVID-19 in relation to each testing. Follow-up will be through electronic patient records and national registries.
We will compare the group of health care personnel with data from a control group of healthy volunteer blood donors from the Danish Blood Donor Study.
The aim of the study is to investigate the proportion of hospital staff with SARS-CoV-2 antibodies during the study period compared to a control group representing the Danish population. We will compare the test characteristics of the two methods of testing, a point of care test and Elisa.
Further, we will investigate the extent to which prior immunization or infection is protective for future infection with COVID-19.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44698
- >18 years old
- Consent to participation
- Employed at a Hospital in the Capitial Region of Denmark
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Hospital Staff in the Capital Region of Denmark IgM and IgG diagnostic kits to SARS-CoV-2 - Healthy volunteer blood donors IgM and IgG diagnostic kits to SARS-CoV-2 - Healthy volunteer blood donors Elisa-test for IgM and IgG to SARS-CoV-2 - Hospital Staff in the Capital Region of Denmark Elisa-test for IgM and IgG to SARS-CoV-2 -
- Primary Outcome Measures
Name Time Method Comparison of the point of care test and Elisa 5 months Comparison of the resultat from the point of care test and with results from Elisa
Re-infection rate 360 days Number of patients, who were tested positive for antibodies on an earlier test and later are infected with COVID-19
Positive IgM/IgG tests 5 month Proportion of hospital staff who have a positive IgM/IgG tests for antibodies to SARS-CoV-2 on point of care test and/or Elisa compared to the background population
IgM/IgG positive participants on follow-up test 5 months Proportion of IgM/IgG positive participants with a lasting immune response. This will be the participants who are still positive on follow-up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (14)
Psykiatrisk Center Sankt Hans
🇩🇰Roskilde, Denmark
Psykiatrisk Center Amager
🇩🇰Copenhagen, Denmark
Rigshospitalet
🇩🇰Copenhagen, Denmark
Bornholms Hospital
🇩🇰Rønne, Denmark
Psykiatrisk Center Bornholm
🇩🇰Rønne, Denmark
Psykiatrisk Center Ballerup
🇩🇰Ballerup, Denmark
Psykiatrisk Center Stolpegaard
🇩🇰Gentofte, Denmark
Herlev Hospital
🇩🇰Herlev, Region Hovedstaden, Denmark
Bispebjerg Hospital
🇩🇰København NV, Region Hovedstaden, Denmark
Psykiatrisk Center København
🇩🇰Copenhagen, Denmark
Børne- og Ungdomspsykiatrisk Center
🇩🇰Glostrup, Denmark
Psykiatrisk Center Glostrup
🇩🇰Glostrup, Denmark
Nordsjaellands Hospital
🇩🇰Hillerød, Denmark
Psykiatrisk Center Nordsjælland
🇩🇰Hillerød, Denmark